Day One Biopharmaceuticals, Inc. (DAWN)

DAWN Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	43.28	124.97	230.78	85.26	284.31	43.73
Short-Term Investments	408.3	406.75	135.56	257.01	-	-
Cash & Short-Term Investments	451.58	531.72	366.35	342.27	284.31	43.73
Cash Growth	-19.13%	45.14%	7.03%	20.39%	550.18%	59.99%
Receivables	16.7	13.88	-	-	-	-
Inventory	7.06	3.32	-	-	-	-
Prepaid Expenses	4.82	5.2	3.27	2.6	2.96	0.08
Other Current Assets	9.82	8.22	5.66	3.01	2.1	1.26
Total Current Assets	489.97	562.33	375.27	347.87	289.37	45.07
Property, Plant & Equipment	4.68	4.71	0.56	0.72	0.28	0.48
Other Intangible Assets	18.82	15.63	-	-	-	-
Long-Term Deferred Charges	-	-	-	-	-	0.04
Other Long-Term Assets	0.32	0.12	0.21	0.47	0.17	0.07
Total Assets	513.78	582.79	376.05	349.06	289.82	45.66
Accounts Payable	5.78	3.26	2.58	0.26	1.74	0.2
Accrued Expenses	48.21	56.46	25.48	15.77	6.61	1.57
Current Portion of Leases	0.16	0.01	0.41	0.41	0.2	0.2
Current Unearned Revenue	2.32	1.55	-	-	-	-
Other Current Liabilities	-	12.16	1.04	0.18	0.1	0.03
Total Current Liabilities	56.47	73.45	29.51	16.62	8.66	2
Long-Term Leases	2.73	2.59	-	0.41	0.02	0.2
Long-Term Unearned Revenue	2.95	3.23	-	-	-	-
Other Long-Term Liabilities	0.76	0.76	-	-	-	-
Total Liabilities	62.91	80.04	29.51	17.02	8.67	2.2
Common Stock	0.01	0.01	0.01	0.01	0.01	2
Additional Paid-In Capital	1,091	1,057	805.11	601.77	408.63	-
Retained Earnings	-640.13	-554.08	-458.59	-269.67	-127.49	-56.84
Comprehensive Income & Other	0.07	0.08	0.01	-0.07	-	0.64
Total Common Equity	450.87	502.75	346.54	332.04	281.15	-54.21
Minority Interest	-	-	-	-	-	5.7
Shareholders' Equity	450.87	502.75	346.54	332.04	281.15	43.46
Total Liabilities & Equity	513.78	582.79	376.05	349.06	289.82	45.66
Total Debt	2.89	2.6	0.41	0.81	0.22	0.4
Net Cash (Debt)	448.69	529.12	365.94	341.46	284.09	43.33
Net Cash Growth	-19.27%	44.59%	7.17%	20.19%	555.70%	58.52%
Net Cash Per Share	4.36	5.68	4.59	5.22	7.69	7.84
Filing Date Shares Outstanding	102.68	101.35	87.38	73.59	61.95	2.6
Total Common Shares Outstanding	102.68	101.12	87.23	73.46	61.95	2.6
Working Capital	433.51	488.88	345.77	331.26	280.71	43.08
Book Value Per Share	4.39	4.97	3.97	4.52	4.54	-20.88
Tangible Book Value	432.05	487.12	346.54	332.04	281.15	-54.21
Tangible Book Value Per Share	4.21	4.82	3.97	4.52	4.54	-20.88
Machinery	-	-	-	-	0.08	0.08
Leasehold Improvements	-	-	-	-	0.02	0.02

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q